Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Other financing activities: 2011-2025

Historic Other financing activities for Altimmune (ALT) over the last 2 years, with Sep 2025 value amounting to $322,000.

  • Altimmune's Other financing activities was N/A to $322,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $633,063, marking a year-over-year change of. This contributed to the annual value of $612,218 for FY2016, which is N/A change from last year.
  • Latest data reveals that Altimmune reported Other financing activities of $322,000 as of Q3 2025, which was up 1,654.67% from $18,351 recorded in Q1 2018.
  • In the past 5 years, Altimmune's Other financing activities ranged from a high of $322,000 in Q3 2025 and a low of $322,000 during Q3 2025.
  • Over the past 1 years, Altimmune's median Other financing activities value was $322,000 (recorded in 2025), while the average stood at $322,000.